Nuclear Medicine Market Size, Trends, Analysis, and Outlook By Product (SPECT Diagnostic Products, PET Diagnostic Products, Therapeutic Products, Alpha Emitters, Beta Emitters, Brachytherapy), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Others), by Country, Segment, and Companies, 2024-2032
The global Nuclear Medicine market size is poised to register 12.4% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Nuclear Medicine market across By Product (SPECT Diagnostic Products, PET Diagnostic Products, Therapeutic Products, Alpha Emitters, Beta Emitters, Brachytherapy), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Others)
The future of the nuclear medicine market is influenced by advancements in radiopharmaceuticals, increasing prevalence of cancer and cardiovascular diseases, and growing demand for molecular imaging techniques. Nuclear medicine utilizes radioactive tracers to visualize and diagnose various medical conditions, including cancer, heart disease, and neurological disorders. With the rise of precision medicine and personalized imaging, there is a growing interest in nuclear medicine for targeted therapy planning, treatment monitoring, and patient stratification. Further, technological innovations such as PET-CT, SPECT-CT, and theranostic agents are driving the development of next-generation nuclear imaging modalities with improved sensitivity, specificity, and spatial resolution. Over the forecast period to 2030, expanding applications in oncology, cardiology, and neurology, coupled with increasing investments in radiopharmaceutical research and regulatory approvals for novel imaging agents, are expected to drive market growth and innovation, enabling healthcare providers to deliver more accurate diagnoses and personalized treatment strategies.
Nuclear Medicine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Nuclear Medicine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Nuclear Medicine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Nuclear Medicine industry.
Key market trends defining the global Nuclear Medicine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Nuclear Medicine Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Nuclear Medicine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Nuclear Medicine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Nuclear Medicine industry
Leading Nuclear Medicine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Nuclear Medicine companies.
Nuclear Medicine Market Study- Strategic Analysis Review
The Nuclear Medicine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Nuclear Medicine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Nuclear Medicine Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Nuclear Medicine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Nuclear Medicine market segments. Similarly, Strong market demand is encouraging Canadian Nuclear Medicine companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Nuclear Medicine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Nuclear Medicine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Nuclear Medicine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Nuclear Medicine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Nuclear Medicine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Nuclear Medicine in Asia Pacific. In particular, China, India, and South East Asian Nuclear Medicine markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Nuclear Medicine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Nuclear Medicine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Nuclear Medicine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Nuclear Medicine.
Nuclear Medicine Market Company Profiles
The global Nuclear Medicine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bayer AG, Bracco Imaging S.p.A., Cardinal Health Inc, Curium Pharma, Eckert & Ziegler Group, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Isotope JSC, Jubilant DraxImage Inc, Lantheus Holdings Inc, Nordion Inc, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, PharmaLogic Holdings Corp, Siemens Healthineers AG.
Recent Nuclear Medicine Market Developments
The global Nuclear Medicine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Nuclear Medicine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
SPECT Diagnostic Products
-TC-99m
-TL-201
-GA-67
-I-123
-Others
PET Diagnostic Products
-F-18
-SR-82/RB-82
-Others
Therapeutic Products
Alpha Emitters
Beta Emitters
Brachytherapy
By Application
Cardiology
Neurology
Oncology
Thyroid
Lymphoma
Bone Metastasis
Endocrine Tumor
Others
By End-User
Hospitals & Clinics
Diagnostic Centers
Others
Geographical Segmentation:
Bayer AG
Bracco Imaging S.p.A.
Cardinal Health Inc
Curium Pharma
Eckert & Ziegler Group
Eczacibasi-Monrol Nuclear Products
GE Healthcare
Isotope JSC
Jubilant DraxImage Inc
Lantheus Holdings Inc
Nordion Inc
NorthStar Medical Radioisotopes LLC
NTP Radioisotopes SOC Ltd
PharmaLogic Holdings Corp
Siemens Healthineers AG
Formats Available: Excel, PDF, and PPT
The future of the nuclear medicine market is influenced by advancements in radiopharmaceuticals, increasing prevalence of cancer and cardiovascular diseases, and growing demand for molecular imaging techniques. Nuclear medicine utilizes radioactive tracers to visualize and diagnose various medical conditions, including cancer, heart disease, and neurological disorders. With the rise of precision medicine and personalized imaging, there is a growing interest in nuclear medicine for targeted therapy planning, treatment monitoring, and patient stratification. Further, technological innovations such as PET-CT, SPECT-CT, and theranostic agents are driving the development of next-generation nuclear imaging modalities with improved sensitivity, specificity, and spatial resolution. Over the forecast period to 2030, expanding applications in oncology, cardiology, and neurology, coupled with increasing investments in radiopharmaceutical research and regulatory approvals for novel imaging agents, are expected to drive market growth and innovation, enabling healthcare providers to deliver more accurate diagnoses and personalized treatment strategies.
Nuclear Medicine Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Nuclear Medicine market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Nuclear Medicine survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Nuclear Medicine industry.
Key market trends defining the global Nuclear Medicine demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Nuclear Medicine Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Nuclear Medicine industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Nuclear Medicine companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Nuclear Medicine industry
Leading Nuclear Medicine companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Nuclear Medicine companies.
Nuclear Medicine Market Study- Strategic Analysis Review
The Nuclear Medicine market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Nuclear Medicine industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Nuclear Medicine Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Nuclear Medicine Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Nuclear Medicine market segments. Similarly, Strong market demand is encouraging Canadian Nuclear Medicine companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Nuclear Medicine market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Nuclear Medicine Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Nuclear Medicine industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Nuclear Medicine market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Nuclear Medicine Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Nuclear Medicine in Asia Pacific. In particular, China, India, and South East Asian Nuclear Medicine markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Nuclear Medicine Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Nuclear Medicine Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Nuclear Medicine market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Nuclear Medicine.
Nuclear Medicine Market Company Profiles
The global Nuclear Medicine market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Bayer AG, Bracco Imaging S.p.A., Cardinal Health Inc, Curium Pharma, Eckert & Ziegler Group, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Isotope JSC, Jubilant DraxImage Inc, Lantheus Holdings Inc, Nordion Inc, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, PharmaLogic Holdings Corp, Siemens Healthineers AG.
Recent Nuclear Medicine Market Developments
The global Nuclear Medicine market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Nuclear Medicine Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
SPECT Diagnostic Products
-TC-99m
-TL-201
-GA-67
-I-123
-Others
PET Diagnostic Products
-F-18
-SR-82/RB-82
-Others
Therapeutic Products
Alpha Emitters
Beta Emitters
Brachytherapy
By Application
Cardiology
Neurology
Oncology
Thyroid
Lymphoma
Bone Metastasis
Endocrine Tumor
Others
By End-User
Hospitals & Clinics
Diagnostic Centers
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Bayer AG
Bracco Imaging S.p.A.
Cardinal Health Inc
Curium Pharma
Eckert & Ziegler Group
Eczacibasi-Monrol Nuclear Products
GE Healthcare
Isotope JSC
Jubilant DraxImage Inc
Lantheus Holdings Inc
Nordion Inc
NorthStar Medical Radioisotopes LLC
NTP Radioisotopes SOC Ltd
PharmaLogic Holdings Corp
Siemens Healthineers AG
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Nuclear Medicine Market Overview and Key Findings, 2024
1.2 Nuclear Medicine Market Size and Growth Outlook, 2021- 2030
1.3 Nuclear Medicine Market Growth Opportunities to 2030
1.4 Key Nuclear Medicine Market Trends and Challenges
1.4.1 Nuclear Medicine Market Drivers and Trends
1.4.2 Nuclear Medicine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Nuclear Medicine Companies
2. NUCLEAR MEDICINE MARKET SIZE OUTLOOK TO 2030
2.1 Nuclear Medicine Market Size Outlook, USD Million, 2021- 2030
2.2 Nuclear Medicine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NUCLEAR MEDICINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NUCLEAR MEDICINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
SPECT Diagnostic Products
-TC-99m
-TL-201
-GA-67
-I-123
-Others
PET Diagnostic Products
-F-18
-SR-82/RB-82
-Others
Therapeutic Products
Alpha Emitters
Beta Emitters
Brachytherapy
By Application
Cardiology
Neurology
Oncology
Thyroid
Lymphoma
Bone Metastasis
Endocrine Tumor
Others
By End-User
Hospitals & Clinics
Diagnostic Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Nuclear Medicine Market, 2025
5.2 Asia Pacific Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Nuclear Medicine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Nuclear Medicine Market, 2025
5.5 Europe Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.6 Europe Nuclear Medicine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Nuclear Medicine Market, 2025
5.8 North America Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.9 North America Nuclear Medicine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Nuclear Medicine Market, 2025
5.11 South America Pacific Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.12 South America Nuclear Medicine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Nuclear Medicine Market, 2025
5.14 Middle East Africa Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Nuclear Medicine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Nuclear Medicine Market Size Outlook and Revenue Growth Forecasts
6.2 US Nuclear Medicine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Nuclear Medicine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Nuclear Medicine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Nuclear Medicine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Nuclear Medicine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Nuclear Medicine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Nuclear Medicine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Nuclear Medicine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Nuclear Medicine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Nuclear Medicine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Nuclear Medicine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Nuclear Medicine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Nuclear Medicine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Nuclear Medicine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Nuclear Medicine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Nuclear Medicine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Nuclear Medicine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Nuclear Medicine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Nuclear Medicine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Nuclear Medicine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Nuclear Medicine Industry Drivers and Opportunities
7. NUCLEAR MEDICINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NUCLEAR MEDICINE COMPANY PROFILES
8.1 Profiles of Leading Nuclear Medicine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bayer AG
Bracco Imaging S.p.A.
Cardinal Health Inc
Curium Pharma
Eckert & Ziegler Group
Eczacibasi-Monrol Nuclear Products
GE Healthcare
Isotope JSC
Jubilant DraxImage Inc
Lantheus Holdings Inc
Nordion Inc
NorthStar Medical Radioisotopes LLC
NTP Radioisotopes SOC Ltd
PharmaLogic Holdings Corp
Siemens Healthineers AG.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Nuclear Medicine Market Overview and Key Findings, 2024
1.2 Nuclear Medicine Market Size and Growth Outlook, 2021- 2030
1.3 Nuclear Medicine Market Growth Opportunities to 2030
1.4 Key Nuclear Medicine Market Trends and Challenges
1.4.1 Nuclear Medicine Market Drivers and Trends
1.4.2 Nuclear Medicine Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Nuclear Medicine Companies
2. NUCLEAR MEDICINE MARKET SIZE OUTLOOK TO 2030
2.1 Nuclear Medicine Market Size Outlook, USD Million, 2021- 2030
2.2 Nuclear Medicine Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NUCLEAR MEDICINE MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NUCLEAR MEDICINE MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
SPECT Diagnostic Products
-TC-99m
-TL-201
-GA-67
-I-123
-Others
PET Diagnostic Products
-F-18
-SR-82/RB-82
-Others
Therapeutic Products
Alpha Emitters
Beta Emitters
Brachytherapy
By Application
Cardiology
Neurology
Oncology
Thyroid
Lymphoma
Bone Metastasis
Endocrine Tumor
Others
By End-User
Hospitals & Clinics
Diagnostic Centers
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Nuclear Medicine Market, 2025
5.2 Asia Pacific Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Nuclear Medicine Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Nuclear Medicine Market, 2025
5.5 Europe Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.6 Europe Nuclear Medicine Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Nuclear Medicine Market, 2025
5.8 North America Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.9 North America Nuclear Medicine Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Nuclear Medicine Market, 2025
5.11 South America Pacific Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.12 South America Nuclear Medicine Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Nuclear Medicine Market, 2025
5.14 Middle East Africa Nuclear Medicine Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Nuclear Medicine Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Nuclear Medicine Market Size Outlook and Revenue Growth Forecasts
6.2 US Nuclear Medicine Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Nuclear Medicine Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Nuclear Medicine Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Nuclear Medicine Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Nuclear Medicine Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Nuclear Medicine Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Nuclear Medicine Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Nuclear Medicine Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Nuclear Medicine Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Nuclear Medicine Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Nuclear Medicine Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Nuclear Medicine Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Nuclear Medicine Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Nuclear Medicine Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Nuclear Medicine Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Nuclear Medicine Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Nuclear Medicine Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Nuclear Medicine Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Nuclear Medicine Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Nuclear Medicine Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Nuclear Medicine Industry Drivers and Opportunities
7. NUCLEAR MEDICINE MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NUCLEAR MEDICINE COMPANY PROFILES
8.1 Profiles of Leading Nuclear Medicine Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Bayer AG
Bracco Imaging S.p.A.
Cardinal Health Inc
Curium Pharma
Eckert & Ziegler Group
Eczacibasi-Monrol Nuclear Products
GE Healthcare
Isotope JSC
Jubilant DraxImage Inc
Lantheus Holdings Inc
Nordion Inc
NorthStar Medical Radioisotopes LLC
NTP Radioisotopes SOC Ltd
PharmaLogic Holdings Corp
Siemens Healthineers AG.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
